RMD · Resmed Inc
Market Cap
$33.37B
Shares
144.25M
RMD metrics
100 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$231.36
Market cap
$33.37B
Price action
19 metricsPrice change (1W)
-2.2%
Price change (30D)
+7.5%
Price change (3M)
+26.6%
Price change (6M)
-10.4%
Price change (YTD)
-3.9%
Price change (1Y)
-15.7%
Trailing year
Price change (5Y)
-19.7%
52-week high
$283.28
52-week low
$182.82
Change from 52-week high
-18.3%
Change from 52-week low
+26.6%
Annualized volatility
28.5%
Beta
0.5
RSI (14D)
56.9
Price vs SMA 50
+8.5%
Price vs SMA 200
+1.2%
Avg volume (3M)
1.50M
Relative volume
0.7
Average dollar volume
$312.87M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
144.25M
Valuation
12 metricsP / E (TTM)
22.2
Trailing earnings · reciprocal yield 4.5%
PEG ratio
9.5
EV / revenue
5.8×
reciprocal yield 17.4%
EV / EBITDA
15.6×
reciprocal yield 6.4%
EV / EBIT
17.3×
reciprocal yield 5.8%
P / sales
5.9×
reciprocal yield 16.9%
P / book
5.1
reciprocal yield 19.7%
FCF yield
4.9%
TTM · current market cap
Buyback yield
2.1%
P / FCF
20.2
reciprocal yield 4.9%
P / operating cash flow
18.5
reciprocal yield 5.4%
Earnings yield
4.6%
Historical valuation
8 metricsP / E historical average (3Y)
27.3×
reciprocal yield 3.7%
P / E historical average (5Y)
37.5×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
6.6×
reciprocal yield 15.1%
EV / revenue historical average (5Y)
7.3×
reciprocal yield 13.8%
EV / EBIT historical average (3Y)
21.8×
reciprocal yield 4.6%
EV / EBIT historical average (5Y)
25.0×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
19.4×
reciprocal yield 5.2%
EV / EBITDA historical average (5Y)
21.9×
reciprocal yield 4.6%
Dividends & buybacks
7 metricsDividend yield
1.1%
Trailing 12 months
Payout ratio
23.0%
Shareholder yield
3.1%
Dividend / share (TTM)
$2.46
Dividend growth YoY
+12.3%
Dividend growth streak
5
Last ex-dividend
2026-08-20
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
61.1%
Operating margin
33.4%
Trailing 12 months
Net margin
26.9%
Gross profit (TTM)
$3.45B
Operating profit (TTM)
$1.89B
Net income (TTM)
$1.52B
Trailing 12 months
Diluted EPS (TTM)
$10.43
FCF margin
29.2%
Effective tax rate
20.6%
Growth
11 metricsRevenue growth YoY
+8.6%
Year over year
Net income growth YoY
+1.0%
Revenue (TTM)
$5.65B
Trailing 12 months
EPS growth YoY
+2.3%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.2%
Revenue CAGR (5Y)
+12.1%
EPS CAGR (3Y)
+19.6%
EPS CAGR (5Y)
+26.3%
FCF CAGR (3Y)
+42.2%
FCF CAGR (5Y)
+21.1%
Quality
14 metricsReturn on equity
23.1%
Return on assets
17.0%
Debt / equity
0.1
Current ratio
3.1
EBITDA (TTM)
$2.09B
Free cash flow (TTM)
$1.65B
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
-0.4
Return on invested capital
25.9%
Trailing 12 months
Net cash
$809.87M
Latest balance sheet
Cash & equivalents
$1.47B
Total assets
$8.97B
Total debt
$659.37M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$1.81B
Capital expenditures (TTM)
$156.28M
R&D (TTM)
$378.29M
SG&A (TTM)
$1.12B
Stock compensation (TTM)
$104.35M
R&D / revenue
6.7%
Stock compensation / revenue
1.8%
Ownership (13F)
3 metrics13F filers
892
13F filer change QoQ
-59
Institutional ownership
69.8%
Short interest
3 metricsShort interest
8.9%
Latest settlement · 7.4 days to cover
Days to cover
7.4d
Short-squeeze score
74 / 100
Insider activity
2 metricsNet insider buying (90D)
−$4.89M
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
943819
CUSIP
761152107
13F (30d)
573 filings
557 filers
Visit website
Investor relations